PT  - JOURNAL ARTICLE
AU  - Huang, Jianzhong
AU  - Soffer, Samuel Z.
AU  - Kim, Eugene S.
AU  - McCrudden, Kimberly W.
AU  - Huang, Joe
AU  - New, Tamara
AU  - Manley, Christina A.
AU  - Middlesworth, William
AU  - O'Toole, Kathleen
AU  - Yamashiro, Darrell J.
AU  - Kandel, Jessica J.
TI  - Vascular Remodeling Marks Tumors That Recur During Chronic Suppression of Angiogenesis<a id="xref-fn-1-1" class="xref-" href="#fn-1"><sup>1</sup></a>1NIH U10 CA13539-27, subcontract 6641 (J. K.), NIH 1 R01 CA08895101-A1 (D. Y.), Pediatric Cancer Foundation, and Sorkin Gift Fund.<strong>Note:</strong> J. Huang and S. Z. Soffer contributed equally to this work.
DP  - 2004 Jan 01
TA  - Molecular Cancer Research
PG  - 36--42
VI  - 2
IP  - 1
4099  - http://mcr.aacrjournals.org/content/2/1/36.short
4100  - http://mcr.aacrjournals.org/content/2/1/36.full
SO  - Mol Cancer Res2004 Jan 01; 2
AB  - The potential for avoiding acquired resistance to therapy has been proposed as one compelling theoretical advantage of antiangiogenic therapy based on the normal genetic status of the target vasculature. However, previous work has demonstrated that tumors may resume growth after initial inhibition if antiangiogenic blockade is continued for an extended period. The mechanisms of this recurrent growth are unclear. In these studies, we characterized molecular changes in vasculature during apparent resumption of xenograft growth after initial inhibition by vascular endothelial growth factor blockade, “metronome” topotecan chemotherapy, and combined agents in a xenograft murine model of human Wilms' tumor. Tumors that grew during antiangiogenic blockade developed as viable clusters surrounding strikingly remodeled vessels. These vessels displayed significant increases in diameter and active proliferation of vascular mural cells and expressed platelet-derived growth factor-B, a factor that functions to enhance vascular integrity via stromal cell recruitment. In addition, remodeled vessels were marked by expression of ephrinB2, required for proper assembly of stromal cells into vasculature. Thus, enhanced vascular stability appears to characterize tumor vessel response to chronic antiangiogenesis, features that potentially support increased perfusion and recurrent tumor growth.